Clinical Guidance

  • Practice Advisory PA
The U.S. Food and Drug Administration Requires Notification of Breast Density in Mammography Reports
April 2023
Updated Clinical Guidance for the Use of Progesterone Supplementation for the Prevention of Recurrent Preterm Birth
April 2023
Practice Advisory to Update the Duration of Breastfeeding
February 2023
Updated Mifepristone REMS Requirements
January 2023
Maternal Immunization
October 2022
Hemoglobinopathies in Pregnancy
August 2022
Preexposure Prophylaxis for the Prevention of Human Immunodeficiency Virus
June 2022
Clinical Guidance for the Integration of the Findings of the Chronic Hypertension and Pregnancy (CHAP) Study
April 2022
Oxygen Supplementation in the Setting of Category II or III Fetal Heart Tracings
January 2022
Counseling Regarding Approach to Delivery After Cesarean and the Use of a Vaginal Birth After Cesarean Calculator
December 2021
Low-Dose Aspirin Use for the Prevention of Preeclampsia and Related Morbidity and Mortality
December 2021
Use of Antenatal Corticosteroids at 22 Weeks of Gestation
September 2021
Use of Nitrous Oxide in Labor and Possible Interaction with Systemic Opioids or Sedatives/Hypnotics
July 2021
Routine Hepatitis C Virus Screening in Pregnant Individuals
May 2021
Updated Cervical Cancer Screening Guidelines
April 2021
Updated Guidelines for Management of Cervical Cancer Screening Abnormalities
October 2020
Voluntary Recall of Certain Lots of Extended-Release Metformin Formulations
September 2020
Options for Peripartum Anticoagulation in Areas Affected by Shortage of Unfractionated Heparin
March 2020
FDA Warning About Fluoroquinolones and Risk of Aortic Ruptures or Tears
November 2019
Cell-free DNA to Screen for Single-Gene Disorders
February 2019